Business & Finance
Michelle Gilson Maintained (BMRN) at Strong Buy with Increased Target to $85 on, Sep 5th, 2013
Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $71 to $85 on, Sep 5th, 2013.
Michelle has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Michelle's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michelle
- Andrew Peters of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $75 on, Monday, June 3rd, 2013
Similar Business and Finance Articles
[ Tue, Jul 16th 2013
] - WOPRAI
[ Fri, Jul 12th 2013
] - WOPRAI
[ Mon, Jun 03rd 2013
] - WOPRAI
[ Wed, Apr 03rd 2013
] - WOPRAI
[ Wed, Mar 20th 2013
] - WOPRAI
[ Wed, Feb 06th 2013
] - WOPRAI
[ Tue, Jan 15th 2013
] - WOPRAI
[ Tue, Nov 06th 2012
] - WOPRAI
[ Mon, Nov 05th 2012
] - WOPRAI
[ Thu, Sep 27th 2012
] - WOPRAI